Table 3.
Iterative PLS-DA modeling cumulative results.
| Metabolite | HCC vs HCV | Cumulative PLS-DA | |||
|---|---|---|---|---|---|
| p-valuea | Sensitivity | Specificity | AUROCb | LVc | |
| Arachidonyl lysolecithin | 2.8E-06 | N/A | N/A | N/A | N/A |
| Dioleoylphosphatidylcholine | 1.0E-05 | N/A | N/A | N/A | N/A |
| 17beta-Estradiol 17-(beta-D-glucuronide) | 1.3E-04 | 0.70 | 0.81 | 0.88 | 3 |
| 3-Deoxyvitamin D3 | 2.2E-04 | 0.70 | 0.81 | 0.88 | 3 |
| Myristoyl L-a-lysophosphatidylcholine | 2.6E-04 | 0.73 | 0.81 | 0.89 | 3 |
| Choline | 6.0E-04 | 0.68 | 0.91 | 0.89 | 3 |
| Uric Acid | 3E-03 | 0.73, 0.73 | 0.95, 0.95 | 0.89, 0.92 | 3,4 |
p-value determined from Welch’s t-test
area under the ROC curve
number of latent variables